SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
DYNEIN DYSFUNCTION IMPAIRS MUSK CLUSTERING AT THE NEUROMUSCULAR JUNCTION:
IMPLICATION FOR NEURODEGENERATION IN ALS
Background
A great deal is known about neuromuscular junction (NMJ) formation but much less is
known on how they are stabilized and maintained. Loss of NMJ integrity occurs in
motor neuron diseases such as amyotrophic lateral sclerosis (ALS). Cytoplasmic
dynein, together with its activator dynactin, forms a large motor protein complex
responsible for the majority of microtubule‐mediated minus‐end transport of organelles.
Studies on mouse models expressing mutations in dynein have shown mild
neurodegeneration linked to defective retrograde transport in neurons and NMJ
defects. Many pieces of evidence have (re) placed the muscle as one of initiating
centers of ALS and because dynein complex has been described as important
protagonists of muscle development, a key question is whether the motor protein
complex can play a role in muscle‐derived pathobiology in ALS.
Objective
To investigate the role of the dynein in the formation and maintenance of the post-synaptic
apparatus and the underlying stabilizing mechanisms.
Discussion & Conclusions
 Dynein is important for the maintenance of the post-synaptic apparatus via control of MuSK localization,
trafficking and clustering at the neuromuscular junction.
 These preliminary data secure our in-vitro differentiation protocol as a robust model to study highly
differentiated fibers recapitulating muscle development in SOD1G93A mice.
 Our findings from SOD1G93A mice revealed that features of the post-synaptic apparatus are impaired in fibers
taken from young mice which are still asymptomatic supporting the hypothesis that muscle development could
be an independent trigger of neuromuscular junction loss and muscle atrophy.
 This novel model could be used as a new tool to study time-based development of neuromuscular structures
in SOD1G93A mice and to test new therapeutic compounds for ALS.
Valérie VILMONT1, Bruno Cadot1 and Edgar R. Gomes1,2
1Myology Research Center, Sorbonne Universités, UPMC Université Paris, Paris, France, 2Instituto di Medicina Molecular, Lisbon, Portugal
Email addresses for correspondence: vilmont@myologygroup.net, er.gomes@gmail.com
Keywords: Dynein, NMJ, Muscle-specific tyrosine kinase, endosomal trafficking, SOD1G93A
A) In vitro models
1-Primary myoblasts were isolated from P7-WT littermates or transgenic pups expressing the
G93A mutant form of human SOD1. Human SOD1 is known to aggregate dynein causing loss
of dynein function..
2-Myoblasts at 70-80% confluence were directed to differentiate to Day 6 (middle point
differentiation) and Day 9 (end point differentiation) on Matrigel support2 in the presence
of agrin to induce AchR clustering which are considered as surrogate NMJ.
3-Myofibers were treated with either small interfering RNAs against dynein (shDHC) or
ciliobrevinD to impair dynein motor function.
4- Post-synaptic features were assessed qualitatively and quantitatively at Day 6 and Day 9 in
conditions cited in 3-
B) Ex vivo model
1- Extensor digitorum longus (EDL) single fibers were isolated from symptomatic SOD1G93A
and littermates and postsynaptic features were assessed.
REFERENCE
1Dobrowolny, JCB, 2005; Dupuis, Exp Neu 2009; Wong and Martin Hum Mol Genet, 2010
2Falcone S et al., EMBO Mol Med, 2014
3http://neuromuscular.wustl.edu/synmg.html
Figure 2. Simplified scheme of the post-synaptic
features at the neuromuscular junction. AchR,
MuSK and rapsyn localization at the post-synaptic
membrane upon agrin-induced AchR clustering3.
Formation of this complex is important for the
maintenance of the post-synaptic structure and thereafter
of the neuromuscular junction.
Figure 4. Comparison between SOD1WT and SOD1G93A single fibers.
A) Representative images of myofibers in SOD1WT and SOD1G93A
isolated fibers stained for α-BTX (magenta), rapsyn (green), MuSK
(red) and DAPI (blue).
B) Representative images of myofibers in SOD1WT and SOD1G93A
isolated fibers stained for α-BTX (magenta), rapsyn (green),
phosphoMuSK (red) and DAPI (blue). Myofiber boundaries are
represented as dashed lines.
C, D, E) Mean intensity of Rapsyn/MuSK/PhosphoMuSK signal in
SOD1WT vs SOD1G93A isolated fibers. Error bars represent sd.
Results
I
SOD1 G93A MOUSE LIFESPAN
ASYMPTOMATIC
P7 pups
SYMPTOMATIC
=30 days =120days
SOD1G93A
Day6
Day9
SOD1G93ASOD1 WT
Figure 1. Dynein is involved in AchR cluster formation and maintenance
A) AchR clusters stained with tetramethylrhodamine-coupled α-Bungarotoxin (BTX) at Day 6 and Day 9 of myofiber differentiation.
Myofiber boundaries are represented as dash lines. Scale bar 10µm.
B) Quantification of AchR clusters number per fiber and AchR cluster length in control vs shDHC conditions at 2 differentiation time
points (days 6 and 9).
C) Quantification of AchR clusters number per fiber and AchR cluster length in ciliobrevinD release assay at 2 differentiation time points
(days 6 and 9).
A
B C
II- Dynein is important for MuSK localization and clustering at AchR clusters
III- AChR clusters and MuSK are affected in neurodegenerative conditions where
dynein function is known to be impaired
Figure 2. Dynein is involved in MuSK localization and clustering
A) MuSK localization in control (fiber with a diese) and shDHC-
transfected myofiber (fiber with asterix). MuSK localization at cell
periphery in control myofiber (arrows) and absence of MuSK at cell
periphery (arrowheads) in shDHC-transfected myofiber. Myofibers
are stained for MuSK (grey) and DAPI (blue).
B) Representative images of myofibers at Day 6 in absence,
presence or after release of ciliobrevinD as indicated. Myofibers
are stained for α-BTX (green), MuSK (Red) and DAPI (blue).
Arrowheads show MuSK localization at cell periphery.
Scale bar 10µm.
Figure 3. SOD1G93A in vitro differentiated myofibers recapitulate pathological features reminiscent of symptomatic SOD1G93A mice.
A) Representative images of SOD1G93A myofibers at Day 6 stained for α-BTX (Magenta), MuSK/phosphoMuSK/Rapsyn (Magenta) and DAPI (blue).
B) Representative images of WT myofibers at Day 9 stained for α-BTX (green), MuSK/phosphoMuSK (Red) and DAPI (blue) and
C) Representative images of SOD1G93A myofibers at Day 9 stained for α-BTX (green), MuSK/PhosphoMuSK (Red) and DAPI (blue). Scale bar 10µm.
A
B C
IV- Isolated fibers obtained from symptomatic SOD1G93A show post-synaptic
alteration
V- MuSK loss at the NMJ is linked to impaired trafficking via dynein-dependent
endosomes trafficking
Figure 5. Stabilization of MuSK clusters at NMJ depends on Rab-mediated dynein
dependent trafficking.
A, C, E) Representative images of myofibers in control, CiliobrevinD treated and released
from ciliobrevinD conditions stained for MuSK (green), Rab4a/Rab7/Rab11 (Red) and DAPI
(blue). Colocalization between Rab4a /Rab7/Rab11 and MuSK clusters is magnified (2x).
Arrows show colocalization points.
B, D, F) Quantification of colocalization coefficients between MuSK and Rab4a/Rab7/Rab11.
Scale bar 10µm.Material & Methods
Experimental approach
In vitro DIFFERENTIATION TIMELINE
Assess three important post-synaptic features in in vitro and ex vivo conditions where
dynein functions are impaired.
AchR (Acetylcholine receptor) clusters
MuSK/ phosphorylated MuSK clusters
Rapsyn clusters
Results
II- Dynein is involved in AchR clustering
Poster n°P116
scramble
shDHC
scramble
shDHC
Rab4=early Rab7=late Rab11=recycling
B D F
Day 9=Day 6=

Weitere ähnliche Inhalte

Was ist angesagt?

Gerstner et al PLoS One 2011a
Gerstner et al PLoS One 2011aGerstner et al PLoS One 2011a
Gerstner et al PLoS One 2011ajrgerstn
 
PYK_the_second_secret
PYK_the_second_secretPYK_the_second_secret
PYK_the_second_secretHugh Morgan
 
Sumida Wu Lehrer Jbc 283 2008 6728
Sumida Wu Lehrer Jbc 283 2008 6728Sumida Wu Lehrer Jbc 283 2008 6728
Sumida Wu Lehrer Jbc 283 2008 6728jpsumida
 
journal.pgen.1003895.PDF
journal.pgen.1003895.PDFjournal.pgen.1003895.PDF
journal.pgen.1003895.PDFYueqin Zhou
 
Presentazione I anno Federica Campana
Presentazione I anno Federica CampanaPresentazione I anno Federica Campana
Presentazione I anno Federica Campanalab13unisa
 
ARF webinar trushina
ARF webinar trushinaARF webinar trushina
ARF webinar trushinaAlzforum
 
Menon BB et al Mucosal Immunol 2015
Menon BB et al Mucosal Immunol 2015Menon BB et al Mucosal Immunol 2015
Menon BB et al Mucosal Immunol 2015Balaraj Menon, Ph.D.
 
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1Kamila du Plessis
 
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)Ahmad Usama
 
Presentazione ii anno campana
Presentazione ii anno campanaPresentazione ii anno campana
Presentazione ii anno campanalab13unisa
 
George Wang's Lab Research at the Martin Lab Yale University
George Wang's Lab Research at the Martin Lab Yale UniversityGeorge Wang's Lab Research at the Martin Lab Yale University
George Wang's Lab Research at the Martin Lab Yale UniversityGeorge Wang
 
molecular markers in muscular dystrophy
molecular markers in muscular dystrophymolecular markers in muscular dystrophy
molecular markers in muscular dystrophyMalar Malar
 
matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)Vijay Avin BR
 
71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...
71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...
71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...Mayi Suárez
 

Was ist angesagt? (20)

JBC2
JBC2JBC2
JBC2
 
Gerstner et al PLoS One 2011a
Gerstner et al PLoS One 2011aGerstner et al PLoS One 2011a
Gerstner et al PLoS One 2011a
 
PYK_the_second_secret
PYK_the_second_secretPYK_the_second_secret
PYK_the_second_secret
 
Biosintesis protein
Biosintesis proteinBiosintesis protein
Biosintesis protein
 
Sumida Wu Lehrer Jbc 283 2008 6728
Sumida Wu Lehrer Jbc 283 2008 6728Sumida Wu Lehrer Jbc 283 2008 6728
Sumida Wu Lehrer Jbc 283 2008 6728
 
journal.pgen.1003895.PDF
journal.pgen.1003895.PDFjournal.pgen.1003895.PDF
journal.pgen.1003895.PDF
 
Presentazione I anno Federica Campana
Presentazione I anno Federica CampanaPresentazione I anno Federica Campana
Presentazione I anno Federica Campana
 
ARF webinar trushina
ARF webinar trushinaARF webinar trushina
ARF webinar trushina
 
Bordet-JPET-2007
Bordet-JPET-2007Bordet-JPET-2007
Bordet-JPET-2007
 
Menon BB et al Mucosal Immunol 2015
Menon BB et al Mucosal Immunol 2015Menon BB et al Mucosal Immunol 2015
Menon BB et al Mucosal Immunol 2015
 
769.full
769.full769.full
769.full
 
bbrc aghdam 2013
bbrc aghdam 2013bbrc aghdam 2013
bbrc aghdam 2013
 
Matrixmetalloproteinase
MatrixmetalloproteinaseMatrixmetalloproteinase
Matrixmetalloproteinase
 
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
 
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
 
Presentazione ii anno campana
Presentazione ii anno campanaPresentazione ii anno campana
Presentazione ii anno campana
 
George Wang's Lab Research at the Martin Lab Yale University
George Wang's Lab Research at the Martin Lab Yale UniversityGeorge Wang's Lab Research at the Martin Lab Yale University
George Wang's Lab Research at the Martin Lab Yale University
 
molecular markers in muscular dystrophy
molecular markers in muscular dystrophymolecular markers in muscular dystrophy
molecular markers in muscular dystrophy
 
matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)
 
71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...
71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...
71st ICREA Colloquium - Intrinsically disordered proteins (IDPs) the challeng...
 

Ähnlich wie Poster 13 12 15-Valérie Vilmont-P116-final

Using Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative diseaseUsing Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative diseaseAnn-Marie Roche
 
Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...Shaun Croft, MScR
 
J Neurochem 2003
J Neurochem 2003J Neurochem 2003
J Neurochem 2003Raul Pardo
 
International Journal of Molecular SciencesArticle
 International Journal of Molecular SciencesArticle International Journal of Molecular SciencesArticle
International Journal of Molecular SciencesArticleMargaritoWhitt221
 
Alzheimer 'Disease-in-a-Dish' and Development of Novel Therapeutics
Alzheimer 'Disease-in-a-Dish' and Development of Novel TherapeuticsAlzheimer 'Disease-in-a-Dish' and Development of Novel Therapeutics
Alzheimer 'Disease-in-a-Dish' and Development of Novel TherapeuticsUniversity of Texas at San Antonio
 
Natpro_poster_2015_final
Natpro_poster_2015_finalNatpro_poster_2015_final
Natpro_poster_2015_finalHongnan Cao
 
Enzyme Discovery for Natural Product Biosynthesis
Enzyme Discovery for Natural Product BiosynthesisEnzyme Discovery for Natural Product Biosynthesis
Enzyme Discovery for Natural Product BiosynthesisHongnan Cao
 
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...Simon Gemble
 
maranickel_UROproposal
maranickel_UROproposalmaranickel_UROproposal
maranickel_UROproposalMara Nickel
 
Spines, plasticity, and cognition in alzheimer model mice.
Spines, plasticity, and cognition in alzheimer model mice.Spines, plasticity, and cognition in alzheimer model mice.
Spines, plasticity, and cognition in alzheimer model mice.shiraknafo
 
Spires jones and knafo np
Spires jones and knafo npSpires jones and knafo np
Spires jones and knafo npshiraknafo
 
Actual Poster for SIP
Actual Poster for SIPActual Poster for SIP
Actual Poster for SIPRandy Cruz
 

Ähnlich wie Poster 13 12 15-Valérie Vilmont-P116-final (20)

Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury
Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain InjuryEffect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury
Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury
 
Article_M2
Article_M2Article_M2
Article_M2
 
Using Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative diseaseUsing Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative disease
 
BBI 2007
BBI 2007BBI 2007
BBI 2007
 
2012-JCI
2012-JCI2012-JCI
2012-JCI
 
Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...
 
J Neurochem 2003
J Neurochem 2003J Neurochem 2003
J Neurochem 2003
 
In press
In pressIn press
In press
 
International Journal of Molecular SciencesArticle
 International Journal of Molecular SciencesArticle International Journal of Molecular SciencesArticle
International Journal of Molecular SciencesArticle
 
Alzheimer 'Disease-in-a-Dish' and Development of Novel Therapeutics
Alzheimer 'Disease-in-a-Dish' and Development of Novel TherapeuticsAlzheimer 'Disease-in-a-Dish' and Development of Novel Therapeutics
Alzheimer 'Disease-in-a-Dish' and Development of Novel Therapeutics
 
Natpro_poster_2015_final
Natpro_poster_2015_finalNatpro_poster_2015_final
Natpro_poster_2015_final
 
Enzyme Discovery for Natural Product Biosynthesis
Enzyme Discovery for Natural Product BiosynthesisEnzyme Discovery for Natural Product Biosynthesis
Enzyme Discovery for Natural Product Biosynthesis
 
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
 
Research Article Presentation.pptx
Research Article Presentation.pptxResearch Article Presentation.pptx
Research Article Presentation.pptx
 
maranickel_UROproposal
maranickel_UROproposalmaranickel_UROproposal
maranickel_UROproposal
 
Spines, plasticity, and cognition in alzheimer model mice.
Spines, plasticity, and cognition in alzheimer model mice.Spines, plasticity, and cognition in alzheimer model mice.
Spines, plasticity, and cognition in alzheimer model mice.
 
Spires jones and knafo np
Spires jones and knafo npSpires jones and knafo np
Spires jones and knafo np
 
Actual Poster for SIP
Actual Poster for SIPActual Poster for SIP
Actual Poster for SIP
 
Scientifi c Journal of Multiple Sclerosis
Scientifi c Journal of Multiple SclerosisScientifi c Journal of Multiple Sclerosis
Scientifi c Journal of Multiple Sclerosis
 
kellyoh_sciencepub
kellyoh_sciencepubkellyoh_sciencepub
kellyoh_sciencepub
 

Poster 13 12 15-Valérie Vilmont-P116-final

  • 1. DYNEIN DYSFUNCTION IMPAIRS MUSK CLUSTERING AT THE NEUROMUSCULAR JUNCTION: IMPLICATION FOR NEURODEGENERATION IN ALS Background A great deal is known about neuromuscular junction (NMJ) formation but much less is known on how they are stabilized and maintained. Loss of NMJ integrity occurs in motor neuron diseases such as amyotrophic lateral sclerosis (ALS). Cytoplasmic dynein, together with its activator dynactin, forms a large motor protein complex responsible for the majority of microtubule‐mediated minus‐end transport of organelles. Studies on mouse models expressing mutations in dynein have shown mild neurodegeneration linked to defective retrograde transport in neurons and NMJ defects. Many pieces of evidence have (re) placed the muscle as one of initiating centers of ALS and because dynein complex has been described as important protagonists of muscle development, a key question is whether the motor protein complex can play a role in muscle‐derived pathobiology in ALS. Objective To investigate the role of the dynein in the formation and maintenance of the post-synaptic apparatus and the underlying stabilizing mechanisms. Discussion & Conclusions  Dynein is important for the maintenance of the post-synaptic apparatus via control of MuSK localization, trafficking and clustering at the neuromuscular junction.  These preliminary data secure our in-vitro differentiation protocol as a robust model to study highly differentiated fibers recapitulating muscle development in SOD1G93A mice.  Our findings from SOD1G93A mice revealed that features of the post-synaptic apparatus are impaired in fibers taken from young mice which are still asymptomatic supporting the hypothesis that muscle development could be an independent trigger of neuromuscular junction loss and muscle atrophy.  This novel model could be used as a new tool to study time-based development of neuromuscular structures in SOD1G93A mice and to test new therapeutic compounds for ALS. Valérie VILMONT1, Bruno Cadot1 and Edgar R. Gomes1,2 1Myology Research Center, Sorbonne Universités, UPMC Université Paris, Paris, France, 2Instituto di Medicina Molecular, Lisbon, Portugal Email addresses for correspondence: vilmont@myologygroup.net, er.gomes@gmail.com Keywords: Dynein, NMJ, Muscle-specific tyrosine kinase, endosomal trafficking, SOD1G93A A) In vitro models 1-Primary myoblasts were isolated from P7-WT littermates or transgenic pups expressing the G93A mutant form of human SOD1. Human SOD1 is known to aggregate dynein causing loss of dynein function.. 2-Myoblasts at 70-80% confluence were directed to differentiate to Day 6 (middle point differentiation) and Day 9 (end point differentiation) on Matrigel support2 in the presence of agrin to induce AchR clustering which are considered as surrogate NMJ. 3-Myofibers were treated with either small interfering RNAs against dynein (shDHC) or ciliobrevinD to impair dynein motor function. 4- Post-synaptic features were assessed qualitatively and quantitatively at Day 6 and Day 9 in conditions cited in 3- B) Ex vivo model 1- Extensor digitorum longus (EDL) single fibers were isolated from symptomatic SOD1G93A and littermates and postsynaptic features were assessed. REFERENCE 1Dobrowolny, JCB, 2005; Dupuis, Exp Neu 2009; Wong and Martin Hum Mol Genet, 2010 2Falcone S et al., EMBO Mol Med, 2014 3http://neuromuscular.wustl.edu/synmg.html Figure 2. Simplified scheme of the post-synaptic features at the neuromuscular junction. AchR, MuSK and rapsyn localization at the post-synaptic membrane upon agrin-induced AchR clustering3. Formation of this complex is important for the maintenance of the post-synaptic structure and thereafter of the neuromuscular junction. Figure 4. Comparison between SOD1WT and SOD1G93A single fibers. A) Representative images of myofibers in SOD1WT and SOD1G93A isolated fibers stained for α-BTX (magenta), rapsyn (green), MuSK (red) and DAPI (blue). B) Representative images of myofibers in SOD1WT and SOD1G93A isolated fibers stained for α-BTX (magenta), rapsyn (green), phosphoMuSK (red) and DAPI (blue). Myofiber boundaries are represented as dashed lines. C, D, E) Mean intensity of Rapsyn/MuSK/PhosphoMuSK signal in SOD1WT vs SOD1G93A isolated fibers. Error bars represent sd. Results I SOD1 G93A MOUSE LIFESPAN ASYMPTOMATIC P7 pups SYMPTOMATIC =30 days =120days SOD1G93A Day6 Day9 SOD1G93ASOD1 WT Figure 1. Dynein is involved in AchR cluster formation and maintenance A) AchR clusters stained with tetramethylrhodamine-coupled α-Bungarotoxin (BTX) at Day 6 and Day 9 of myofiber differentiation. Myofiber boundaries are represented as dash lines. Scale bar 10µm. B) Quantification of AchR clusters number per fiber and AchR cluster length in control vs shDHC conditions at 2 differentiation time points (days 6 and 9). C) Quantification of AchR clusters number per fiber and AchR cluster length in ciliobrevinD release assay at 2 differentiation time points (days 6 and 9). A B C II- Dynein is important for MuSK localization and clustering at AchR clusters III- AChR clusters and MuSK are affected in neurodegenerative conditions where dynein function is known to be impaired Figure 2. Dynein is involved in MuSK localization and clustering A) MuSK localization in control (fiber with a diese) and shDHC- transfected myofiber (fiber with asterix). MuSK localization at cell periphery in control myofiber (arrows) and absence of MuSK at cell periphery (arrowheads) in shDHC-transfected myofiber. Myofibers are stained for MuSK (grey) and DAPI (blue). B) Representative images of myofibers at Day 6 in absence, presence or after release of ciliobrevinD as indicated. Myofibers are stained for α-BTX (green), MuSK (Red) and DAPI (blue). Arrowheads show MuSK localization at cell periphery. Scale bar 10µm. Figure 3. SOD1G93A in vitro differentiated myofibers recapitulate pathological features reminiscent of symptomatic SOD1G93A mice. A) Representative images of SOD1G93A myofibers at Day 6 stained for α-BTX (Magenta), MuSK/phosphoMuSK/Rapsyn (Magenta) and DAPI (blue). B) Representative images of WT myofibers at Day 9 stained for α-BTX (green), MuSK/phosphoMuSK (Red) and DAPI (blue) and C) Representative images of SOD1G93A myofibers at Day 9 stained for α-BTX (green), MuSK/PhosphoMuSK (Red) and DAPI (blue). Scale bar 10µm. A B C IV- Isolated fibers obtained from symptomatic SOD1G93A show post-synaptic alteration V- MuSK loss at the NMJ is linked to impaired trafficking via dynein-dependent endosomes trafficking Figure 5. Stabilization of MuSK clusters at NMJ depends on Rab-mediated dynein dependent trafficking. A, C, E) Representative images of myofibers in control, CiliobrevinD treated and released from ciliobrevinD conditions stained for MuSK (green), Rab4a/Rab7/Rab11 (Red) and DAPI (blue). Colocalization between Rab4a /Rab7/Rab11 and MuSK clusters is magnified (2x). Arrows show colocalization points. B, D, F) Quantification of colocalization coefficients between MuSK and Rab4a/Rab7/Rab11. Scale bar 10µm.Material & Methods Experimental approach In vitro DIFFERENTIATION TIMELINE Assess three important post-synaptic features in in vitro and ex vivo conditions where dynein functions are impaired. AchR (Acetylcholine receptor) clusters MuSK/ phosphorylated MuSK clusters Rapsyn clusters Results II- Dynein is involved in AchR clustering Poster n°P116 scramble shDHC scramble shDHC Rab4=early Rab7=late Rab11=recycling B D F Day 9=Day 6=